feedback welcome

Vortioxetine-moclobemide

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][draft revision]
 
Line 3: Line 3:
| to = moclobemide
| to = moclobemide
| stop =  
| stop =  
-
{{stopVortioxetine}}  
+
{{Generaldecrease25p3d}}
 +
{{14dWashout}}
| start =  
| start =  
-
* '''Day 8-23:''' a wash-out period of 2 weeks is necessary. <ref name="vortiswitch"> {{Pubmed|24570588 |Katona et al. New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder. 2014 2014 Feb 19;10:349-54}}</ref> <ref name="informatorium">{{KNMP|vortioxetine}}</ref>
+
*a wash-out period of 2 weeks is necessary. <ref name="vortiswitch"> {{Pubmed|24570588 |Katona et al. New generation multi-modal antidepressants: focus on vortioxetine for major depressive disorder. 2014 2014 Feb 19;10:349-54}}</ref> <ref name="informatorium">{{KNMP|vortioxetine}}</ref>
-
* '''Day 24:''' start administration of moclobemide in normal dosage of 300 mg/day.
+
{{MAOIncrease25p14d}}
| caveat = {{caveSS}}
| caveat = {{caveSS}}
}}
}}

Current revision as of 13:07, 16 June 2016

Vortioxetine
Type Antidepressant
Group SMS
links
Medscape Vortioxetine
PubChem 9966051
PubMed Vortioxetine
Kompas (Dutch) Vortioxetine
Wikipedia Vortioxetine
Moclobemide
Type Antidepressant
Group MAO-I
links
Medscape Moclobemide
PubChem 4235
PubMed Moclobemide
Kompas (Dutch) Moclobemide
Wikipedia Moclobemide

Switch medication from vortioxetine to moclobemide.

Nietinrijdenbord.png Stop vortioxetine
Eenrichtingbord.png Start moclobemide
Letopbord.png Cave


The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About